Medical News In a recent study published in the journal Communications Medicine, researchers in Australia and Norway examined how inflammatory and neurological protein levels differ between long coronavirus disease 2019 (COVID-19) and recovery, and how they respond to vaccination and reinfection. According to research, an estimated 5% to 30% of people infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continue to experience symptoms months later, a condition known as long COVID.
Why do some people recover fully, but others suffer fatigue, brain fog, and chronic inflammation? Some researchers think that their immune systems have become dysregulated and continue to react inappropriately; however, there are no conclusive biological markers that define this dysregulation.
Understanding these differences is critical for diagnosis and treatment, and how vaccination and reinfection influence these immune responses is also unclear. Further research is needed to identify reliable biomarkers and clarify long-term immune behavior in affected individuals.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.